A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy

I.M. Lips; C.H. van Gils; A.N.T.J. Kotte; M.E. van Leerdam; S.P.G. Franken; U.A. van der Heide; M. van Vulpen

A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy

Translated title of the contribution: A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy

I.M. Lips
, C.H. van Gils
, A.N.T.J. Kotte
, M.E. van Leerdam
, S.P.G. Franken
, U.A. van der Heide
, M. van Vulpen

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy
Original language	Undefined/Unknown
Pages (from-to)	653-660
Number of pages	8
Journal	International Journal of Radiation Oncology Biology Physics
Volume	83
Issue number	2
Publication status	Published - 2012

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/22099039

Cite this

Lips, I. M., van Gils, C. H., Kotte, A. N. T. J., van Leerdam, M. E., Franken, S. P. G., van der Heide, U. A., & van Vulpen, M. (2012). A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy. International Journal of Radiation Oncology Biology Physics, 83(2), 653-660. http://www.ncbi.nlm.nih.gov/pubmed/22099039

@article{bf529178c93543b0b79f66e9a578b2f5,

title = "A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy",

author = "I.M. Lips and \{van Gils\}, C.H. and A.N.T.J. Kotte and \{van Leerdam\}, M.E. and S.P.G. Franken and \{van der Heide\}, U.A. and \{van Vulpen\}, M.",

year = "2012",

language = "Undefined/Unknown",

volume = "83",

pages = "653--660",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier",

number = "2",

}

Lips, IM, van Gils, CH, Kotte, ANTJ, van Leerdam, ME, Franken, SPG, van der Heide, UA & van Vulpen, M 2012, 'A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy', International Journal of Radiation Oncology Biology Physics, vol. 83, no. 2, pp. 653-660. <http://www.ncbi.nlm.nih.gov/pubmed/22099039>

A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy. / Lips, I.M.; van Gils, C.H.; Kotte, A.N.T.J. et al.
In: International Journal of Radiation Oncology Biology Physics, Vol. 83, No. 2, 2012, p. 653-660.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A double-blind placebo-controlled randomized clinical trial with magnesium oxide to reduce intrafraction prostate motion for prostate cancer radiotherapy

AU - Lips, I.M.

AU - van Gils, C.H.

AU - Kotte, A.N.T.J.

AU - van Leerdam, M.E.

AU - Franken, S.P.G.

AU - van der Heide, U.A.

AU - van Vulpen, M.

PY - 2012

Y1 - 2012

M3 - Article

SN - 0360-3016

VL - 83

SP - 653

EP - 660

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 2

ER -